scholarly journals The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children

2012 ◽  
Vol 18 (1) ◽  
pp. 44 ◽  
Author(s):  
HanaaM El-Karaksy ◽  
HebaM Helmy ◽  
Ghadam Anwar ◽  
AhmadM El-Hennawy ◽  
NehalM El-Koofy ◽  
...  
2021 ◽  
Author(s):  
Hoda Atwa ◽  
Ahmed Ibrahim ◽  
Husseiny Abd-Allah ◽  
Jacklien Labib

Abstract Background Obesity and associated co-morbidities are growing worldwide, including non-alcoholic fatty liver disease (NAFLD), which become one of the leading causes of chronic liver diseases in both children and adults. The aim of this study is to investigate the clinical and biochemical predictors associated with NAFLD among obese children. Materials and Methods Ninety obese children and adolescents, aged 12–18 years, were enrolled in this study. All were subjected to anthropometric measurement; biochemical analysis included fasting blood glucose, serum insulin, serum triglycerides (TG), total cholesterol, high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c) and liver function tests. Ultrasonography was used to diagnose NAFLD. Results The frequency of NAFLD was 38.9% among obese children 68.6% of them met the criteria of metabolic syndrome. Children with NAFLD had significantly higher body mass index, waist circumference, ALT, total cholesterol, LDL-c, TG, fasting insulin, and lower HDL-c compared to patients with normal liver ultrasound (p < 0.05). Insulin resistance was significantly more common among NAFLD group (88.6% vs. 18.2%) (p < 001). Logistic regression analysis revealed that BMI and HOMA-IR are the independent predictors for NAFLD with (P 0.034 and 0.022) respectively Conclusion More than one third of obese children have NAFLD, which is closely linked to metabolic syndrome and insulin resistance.


2014 ◽  
Vol 8 (4) ◽  
pp. e356-e363 ◽  
Author(s):  
Mehmet Boyraz ◽  
Nihal Hatipoğlu ◽  
Erkan Sarı ◽  
Arzu Akçay ◽  
Necati Taşkın ◽  
...  

2009 ◽  
Vol 150 (48) ◽  
pp. 2173-2181 ◽  
Author(s):  
Krisztina Hagymási ◽  
Péter Reismann ◽  
Károly Rácz ◽  
Zsolt Tulassay

The most frequent liver disorder in metabolic syndrome is the nonalcoholic fatty liver disease. Its pathogenesis is a complex, multifactorial process, characterized by insulin resistance and involvement of the endocrine system. Hypothyroidism may lead to nonalcoholic steatohepatitis via hyperlipidemia and obesity. Adult patients with growth hormone deficiency have a metabolic syndrome-like phenotype with obesity and many characteristic metabolic alterations. The chronic activation of the hypothalamic-pituitary-adrenal axis results in metabolic syndrome as well. Cushing’s syndrome has also features of metabolic syndrome. Mild elevation of transaminase activities is commonly seen in patients with adrenal failure. Non-alcoholic steatosis is twice as common in postmenopusal as in premenopausal women and hormonal replacement therapy decreases the risk of steatosis. Insulin resistance, diabetes mellitus type 2, sleeping apnoe syndrome, cardiovascular disorders and non-alcoholic fatty liver disease are more frequent in polycystic ovary syndrome. Hypoandrogenism in males and hyperandrogenism in females may lead to fatty liver via obesity and insulin resistance. Adipokines (leptin, acylation stimulating protein, adiponectin) have a potential role in the pathogenesis of nonalcoholic fatty liver. The alterations of endocrine system must be considered in the background of cryptogenic liver diseases. The endocrine perspective may help the therapeutic approaches in the future.


2019 ◽  
Author(s):  
mostafa Ahmed EL Foly ◽  
lubna Anas Fawaz ◽  
Ashraf Mohammed Osman ◽  
Salwa Hussien Swelam ◽  
Noura Elbakry

Abstract Abstract Background Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to nonalcoholic steatohepatitis (NASH)leading to fibrosis and potentially cirrhosis, and it is one of the most common causes of liver disease worldwide.NAFLD is associated with other medical conditions suchas metabolic syndrome, obesity, cardiovascular disease and diabetes. Visfatin is an adipocytokine hormone, which exerts an insulin-like effect by binding to the insulin receptor-1, we aim to investigate the correlation between serum Visfatin and both glucose, lipid metabolism and nonalcoholic fatty liver disease in Simple obese children. Methods: This prospective study included 62 children clinically evaluated as obese and 35 apparently healthy children, age and sex matched as controls. Patients were recruited from the emergency department, in-patient wards and out-patient clinics of thepediatric department of EL-Mina University, children's hospital.While controls were collected from healthy school children during day time between September, 2016 and October, 2017. Fasting Visfatin, glucose, hemoglobinA1cand lipid levels were assayed and abdominal ultrasonography was done for detection of NAFLD. Results There was a statistically significant correlation between serum Visfatin level and BMI (p<0.01), cholesterol levels (p< 0.01), triglycerides levels (p< 0.01), LDL levels (p< 0.01), HDL levels (p< 0.01) in both overweight and obese groups. Conclusions: Visfatin plays an important role in regulation of glucose and lipid metabolism, also in inflammation and insulin resistance, suggesting a role in pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Key words: Non-alcoholic fatty liver disease; metabolic syndrome; Visfatin


Sign in / Sign up

Export Citation Format

Share Document